Abstract
It is becoming increasingly clear that the process of angiogenesis is important for tumor growth and metastasis and as such provides an exploitable target for therapeutic intervention. Consequently a number of useful model systems has been developed to investigate the angiogenic process associated with malignancy and to discover new therapeutic strategies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anderson, L. F. (1995) New drug screen assay uses fewer mice, while cutting costs. J. Natl. Cancer Inst. 87, 1213–1214.
Hollingshead, M. G., Alley, M. C., Camallier, R. F., Abbott, B. J., Mayo, J. G., Malspeis, L., and Grever, M. R. (1995) In vitro cultivation of tumor cells in hollow fibers. Life Sci. 57, 131–141.
Phillips, R. M., Pearce, J., Loadman, P. M., Bibby, M. C., Cooper, P. A., Swaine, D. J., and Double, J. A. (1998) Angiogenesis in the hollow fiber tumor model influences drug delivery to tumor cells: Implications for anticancer drug screening programs. Cancer Res. 58, 5263–5266.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc.
About this protocol
Cite this protocol
Phillips, R.M., Bibby, M.C. (2001). Hollow Fiber Assay for Tumor Angiogenesis. In: Murray, J.C. (eds) Angiogenesis Protocols. Methods in Molecular Medicine™, vol 46. Humana Press. https://doi.org/10.1385/1-59259-143-4:087
Download citation
DOI: https://doi.org/10.1385/1-59259-143-4:087
Publisher Name: Humana Press
Print ISBN: 978-0-89603-698-7
Online ISBN: 978-1-59259-143-5
eBook Packages: Springer Protocols